Trial · NCT03945175
Outcomes66
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 66
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Adult ADHD Investigator Symptom Rating Scale (AISRS) Score at End of Placebo Lead-In | Week 2 (End of Placebo Lead-In) | score on a scale | MEAN | |
| PRIMARY | Adult ADHD Investigator Symptom Rating Scale (AISRS) Score at End of Mydayis Treatment | Week 6 (End of Mydayis Treatment) | score on a scale | MEAN | |
| SECONDARY | AISRS: Overall Inattentive (IA) Symptom Subscale Score at End of Placebo Lead-In | Week 2 (End of Placebo Lead-In) | score on a scale | MEAN | |
| SECONDARY | AISRS: Overall Inattentive (IA) Symptom Subscale Score at End of Mydayis Treatment | Week 6 (End of Mydayis Treatment) | score on a scale | MEAN | |
| SECONDARY | AISRS: Hyperactive-Impulsive (HI) Symptom Subscale Score at End of Placebo Lead-In | Week 2 (End of Placebo Lead-In) | score on a scale | MEAN | |
| SECONDARY | AISRS: Hyperactive-Impulsive (HI) Symptom Subscale Score at End of Mydayis Treatment | Week 6 (End of Mydayis Treatment) | score on a scale | MEAN | |
| SECONDARY | Clinical Global Impression-Severity (CGI-S) Scale Score at End of Placebo Lead-In | Week 2 (End of Placebo Lead-In) | score on a scale | MEAN | |
| SECONDARY | Clinical Global Impression-Severity (CGI-S) Scale Score at End of Mydayis Treatment | Week 6 (End of Mydayis Treatment) | score on a scale | MEAN | |
| SECONDARY | 14-Hour Post-Dose Time-Sensitive Adult ADHD Symptom Scale (TASS) Score at End of Placebo Lead-In | Week 2 (End of Placebo Lead-In) | score on a scale | MEAN | |
| SECONDARY | 14-Hour Post-Dose Time-Sensitive Adult ADHD Symptom Scale (TASS) Score at End of Mydayis Treatment | Week 6 (End of Mydayis Treatment) | score on a scale | MEAN | |
| SECONDARY | 14-hour Post-Dose TASS: Inattentive (IA) Symptom Subscale Score at End of Placebo Lead-In | Week 2 (End of Placebo Lead-In) | score on a scale | MEAN | |
| SECONDARY | 14-hour Post-Dose TASS: Inattentive (IA) Symptom Subscale Score at End of Mydayis Treatment | Week 6 (End of Mydayis Treatment) | score on a scale | MEAN | |
| SECONDARY | 14-hour Post-Dose TASS: Hyperactive-Impulsive (HI) Symptom Subscale Score at End of Placebo Lead-In | Week 2 (End of Placebo Lead-In) | score on a scale | MEAN | |
| SECONDARY | 14-hour Post-Dose TASS: Hyperactive-Impulsive (HI) Symptom Subscale Score at End of Mydayis Treatment | Week 6 (End of Mydayis Treatment) | score on a scale | MEAN | |
| SECONDARY | Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A) Score at Week 3 | Week 3 | T-score | MEAN | |
| SECONDARY | Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A) Score at Week 7 | Week 7 | T-score | MEAN | |
| SECONDARY | WebNeuro Neurocognitive Assessment - Working Memory Capacity - Recall Span Score at Baseline | Baseline | digits | MEAN | |
| SECONDARY | WebNeuro Neurocognitive Assessment - Working Memory Capacity - Recall Span Score at Week 7 | Week 7 | score on a scale | MEAN | |
| SECONDARY | WebNeuro Neurocognitive Assessment - Working Memory Capacity - Working Memory Accuracy at Baseline | Baseline | trials correct | MEAN | |
| SECONDARY | WebNeuro Neurocognitive Assessment - Working Memory Capacity - Working Memory Accuracy at Week 7 | Week 7 | trials correct | MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03945175/outcomes